Russia | Science & Technology | October 25, 2026

Russia is expanding research into human longevity, with Maria Vorontsova, an endocrinologist widely identified as the eldest daughter of President Vladimir Putin, predicting that medical advances could help scientists tackle ageing within the next 10 to 20 years.

Vorontsova made the remarks at an event marking the launch of a longevity research laboratory at the Skolkovo Moscow School of Management. The facility is expected to examine how longer life expectancy could affect public policy, economic development and the labour market.

According to reporting by The Moscow Times, Vorontsova described extending human life as a two-stage process. The first stage involves helping people reach their natural lifespan through healthy habits established from childhood, balanced nutrition and regular medical check-ups.

She estimated that people could potentially reach 85 to 90 years through these measures. The second stage, she explained, involves scientific efforts to extend life beyond those limits—an ambition she described as attempting to “cheat God or nature.”

However, she acknowledged that progress in extending human life beyond its natural limits remains limited.

Russia plans anti-ageing drug production

The research initiative comes as Russian authorities increase investment in biotechnology, regenerative medicine and treatments intended to preserve health into old age.

Deputy Prime Minister Tatyana Golikova has previously said Russia intends to begin producing an anti-ageing drug between 2028 and 2030. Officials have also discussed research into cellular ageing and genetic mechanisms associated with age-related changes.

These efforts form part of Russia’s national health technology programme, launched in 2025. The government has announced substantial funding for initiatives aimed at improving healthcare and extending life expectancy.

Nevertheless, the proposed production timeline does not establish that an effective anti-ageing medicine will be available for public use by that date. Clinical trials, safety assessments and regulatory approval remain essential before any new treatment can be established as safe and effective.

The scientific challenge of extending human life

One major obstacle is that ageing itself is not universally classified as a disease for the purposes of drug development and regulatory approval. This can complicate the process of designing clinical trials and establishing the criteria under which an anti-ageing treatment should be prescribed.

Researchers around the world are investigating cellular senescence, genetic regulation, tissue regeneration and other biological processes associated with ageing. However, slowing particular biological processes is not the same as demonstrating that a medicine can substantially extend human lifespan.

Vorontsova’s prediction that medical advances could address ageing within the next two decades therefore remains a forecast, not a confirmed scientific outcome.

Putin’s interest in longevity research

Russia’s longevity programme has attracted international attention partly because of Putin’s reported interest in biotechnology and extending human life.

In September 2025, Putin and Chinese President Xi Jinping were overheard discussing biotechnology, organ transplantation and the possibility of humans living much longer. The exchange drew renewed attention to the scientific ambitions of governments and wealthy individuals investing in life-extension research.

Vorontsova, who heads Moscow State University’s Medical Research and Education Institute, is also associated with state-backed genetic research programmes.

Although media reports have widely identified her as Putin’s daughter, the Kremlin has generally kept details of his family life private.

What the development means

Russia’s latest initiative highlights the growing interest in longevity science as countries confront ageing populations, healthcare costs and the economic consequences of longer lives.

If future research produces safe and effective treatments, the potential benefits could include healthier ageing and a longer period of independent living. But questions remain about affordability, access, long-term safety and whether such treatments could meaningfully extend the maximum human lifespan.

For now, Russia’s plans represent a significant research ambition rather than proof that scientists are close to defeating ageing or achieving immortality.

Note: Russia is pursuing new approaches to extending healthy human life, but the proposed anti-ageing drug remains a developing research goal. Whether the programme produces a treatment that safely slows ageing in humans will depend on scientific evidence, clinical testing and regulatory approval.

Sources and further reading

• The Moscow Times — Putin’s Daughter Says Fear of Death Will Drive Advances Against Aging
• The Moscow Times — Russia Develops ‘Anti-Aging Vaccine’ Targeting Cellular Aging
• The Insider — From Snake Oil to Biohacking: The Quackery and Science of Longevity